Junhe Li

机构：Nanchang University, First Affiliated Hospital of Nanchang University · ORCID：0000-0001-8853-133X

发表论文 42 篇 · 总被引 1230 次 · h-index 19

代表论文

• Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet Oncology · 被引 142)
• Ruscogenin induces ferroptosis in pancreatic cancer cells (2019 · Oncology Reports · 被引 91)
• Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression (2020 · Journal of Experimental & Clinical Cancer Research · 被引 56)
• UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization. (2019 · PubMed · 被引 52)
• NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein (2021 · Frontiers in Oncology · 被引 51)
• USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer (2022 · Oncogene · 被引 41)